ShrijiPatelMDMBA

Retinal Disease

Physician

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Shriji Patel is an ophthalmologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 7 years. He specializes in retinal disease and is experienced in diabetic retinopathy and macular degeneration.

Rutgers New Jersey Medical SchoolResidency, Ophthalmology, 2011 - 2014
Rutgers Health/New Jersey Medical SchoolInternship, Internal Medicine, 2010 - 2011
Rutgers New Jersey Medical SchoolClass of 2010

Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe Start of enrollment: 2019 Sep 01
Completed
Not Applicable

PubMed

Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion.
Theodore Bowe, Collin J Richards, Hana A Mansour, Ferhina S Ali, Jayanth Sridhar
American Journal of Ophthalmology. 2025-01-01
Anatomic Outcomes With Faricimab vs. Aflibercept in the Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular AMD.
Chui Ming Gemmy Cheung, Jennifer I Lim, Siegfried Priglinger, Giuseppe Querques, Philippe Margaron
Ophthalmology. 2024-11-29
Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S.
Meghana Kalavar, Eric A Lovett Jr, Matthew P Nicholas, Adam Ross-Hirsch, Rajinder S Nirwan
American Journal of Ophthalmology. 2024-11-01

Face Down Postoperative Positioning May Not Be Needed for Macular Hole ClosureAugust 2022
Study Describes Female Authorship Trends in Ophthalmic JournalsOctober 2020
Mineralocorticoid Receptor Antagonists Offer an Alternative for Nonresolving CSCMarch 2019
Mineralocorticoid Receptor Antagonists Offer an Alternative for Nonresolving CSCMarch 2019
Deep Learning Models Shows Promise for DME DetectionMarch 2019
Deep Learning Models Shows Promise for DME DetectionMarch 2019
Is Complete Fluid Resolution Necessary in Patients with Choroidal Neovascularization Secondary to AMD?March 2019
Aflibercept Benefits Eyes with Poor Bevacizumab Response for Vein Occlusion-Associated Macular EdemaJanuary 2019
Join now to see all

Reflections on ASRS and the Business of RetinaOctober 18th, 2021
Racial/ethnic Disparities in Ophthalmology Clinical Trials of FDA-Approved DrugsApril 22nd, 2021
Small Percentage of Ophthalmologists Perform Large Proportion of Intravitreal Anti-VEGF InjectionsJuly 4th, 2019
Join now to see all